Study of prevalence of severe community acquired pneumonia in patients having Diabetes more than 1 year admitted to a tertiary care hospital in Eastern India

Manaranjan  Malik; Debasis  Pathi; Subhasree  Mishra; Sidharth S  Pattnaik

Authors

Manaranjan Malik Assistant Professor, Department of General Medicine, KIMS, Bhubaneswar, Odisha, India
Debasis Pathi Assistant Professor, Department of General Medicine, KIMS, Bhubaneswar, Odisha, India
Subhasree Mishra Assistant Professor, Department of General Medicine, KIMS, Bhubaneswar, Odisha, India
Sidharth S Pattnaik Assistant Professor, Department of General Medicine, KIMS, Bhubaneswar, Odisha, India,

Keywords:

Community-acquired pneumonia, diabetes mellitus, glycemic control, hospitalization, prevalence

Abstract

Aim: This study aims to assess the prevalence of CAP among diabetic patients receiving treatment at a tertiary care hospital in Bhubaneswar.

Methods: This retrospective study was conducted at KIMS and PBMH, Bhubaneswar, analyzing hospital records of 100 diabetic patients with CAP over one year. Data were collected on demographics, clinical history, and laboratory findings and analyzed using SPSS version 25.

Results: The majority of participants were aged over 60 years, with a higher prevalence of CAP in uncontrolled diabetes (48%) than in controlled diabetes (45%). Urban residents were predominant in both groups, though low-income individuals had poorer diabetes control. Uncontrolled diabetic patients exhibited more severe symptoms, higher RBS and ESR levels, increased pleural effusion, and longer hospital stays.

Conclusion: Uncontrolled diabetes is associated with a marginally higher prevalence of CAP and increased disease severity. Socioeconomic factors and glycemic control play a crucial role in patient outcomes.

Author Biography

Subhasree Mishra, Assistant Professor, Department of General Medicine, KIMS, Bhubaneswar, Odisha, India

³

References

Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med. 1995;333(24):1618-24. doi: 10.1056/NEJM199512143332408.

Ibrahem RA, El Najjar M, Korani MA, Abdel M. Diabetes Mellitus Prevalence and Burden among Community Acquired Pneumonia Patients. Int J Public Health. 2018;7(1):8-12.

Falguera M, Pifarre R, Martin A, Sheikh A, Moreno A. Etiology and outcome of community-acquired pneumonia in patients with diabetes mellitus. Chest. 2005;128(5):3233-9. doi: 10.1378/chest.128.5.3233.

Afessa B, Green B. Bacterial pneumonia in hospitalized patients with HIV infection: the Pulmonary Complications, ICU Support, and Prognostic Factors of Hospitalized Patients with HIV (PIP) Study. Chest. 2000;117(4):1017-22. doi: 10.1378/chest.117.4.1017.

Carratalà J, Rosón B, Fernández-Sevilla A, Alcaide F, Gudiol F. Bacteremic pneumonia in neutropenic patients with cancer: causes, empirical antibiotic therapy, and outcome. Arch Intern Med. 1998;158(8):868-72. doi: 10.1001/archinte.158.8.868.

Arancibia F, Bauer TT, Ewig S, Mensa J, Gonzalez J, Niederman MS, et al. Community-acquired pneumonia due to gram-negative bacteria and Pseudomonas aeruginosa: incidence, risk, and prognosis. Arch Intern Med. 2002;162(16):1849-58. doi: 10.1001/archinte.162.16.1849.

Ruiz M, Ewig S, Marcos MA, Martinez JA, Arancibia F, Mensa J, et al. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med. 1999;160(2):397-405. doi: 10.1164/ajrccm.160.2.9808045.

Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA, Kapoor WN. Prognosis and outcomes of patients with community-acquired pneumonia: A meta-analysis. JAMA. 1996;275(2):134-41.

Saibal MA, Rahman SH, Nishat L, Sikder NH, Begum SA, Islam MJ, et al. Community-acquired pneumonia in diabetic and non-diabetic hospitalized patients: presentation, causative pathogens, and outcome. Bangladesh Med Res Counc Bull. 2012;38(3):98-103. doi: 10.3329/bmrcb.v38i3.14336.

Valerius NH, Eff C, Hansen NE, Karle H, Nerup J, Søeberg B, Sørensen SF. Neutrophil and lymphocyte function in patients with diabetes mellitus. Acta Med Scand. 1982;211(6):463-7. doi: 10.1111/j.0954-6820.1982.tb01983.x.

Torres A, Blasi F, Dartois N, Akova M. Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease. Thorax. 2015;70(10):984-9. doi: 10.1136/thoraxjnl-2015-206780.

Radha RK, Selvam D. MPV in Uncontrolled & Controlled Diabetics—Its Role as an Indicator of Vascular Complication. J Clin Diagn Res. 2016;10(8):EC22-6. doi: 10.7860/JCDR/2016/21499.8353.

Ljubic S, Balachandran A, Pavlic-Rener I, Barada A, Metelko Z. Pulmonary infections in diabetes mellitus. Diabetol Croatica. 2004;33:115-23.

Lipsky BA, Pecoraro RE, Chen MS, Koepsell TD. Factors affecting staphylococcal colonization among NIDDM outpatients. Diabetes Care. 1987;10(4):483-6. doi: 10.2337/diacare.10.4.483.

Kornum JB, Thomsen RW, Riis A, Lervang HH, Schønheyder HC, Sørensen HT. Type 2 diabetes and pneumonia outcomes: a population-based cohort study. Diabetes Care. 2007;30(9):2251-7. doi: 10.2337/dc06-2417.

Khalil MM, Dayem AMA, Farghaly AAAH, Shehata HM. Pattern of community and hospital-acquired pneumonia in Egyptian military hospitals. Egypt J Chest Dis Tuberc. 2013;62(1):9–16.

Dabe NE, Kefale AT. Antidiabetic Effects of Artemisia Species: A Systematic Review. Anc Sci Life. 2017;36(4):175-181.

Saibal MA, Rahman SH, Nishat L, Sikder NH, Begum SA, Islam MJ, et al. Community-acquired pneumonia in diabetic and non-diabetic hospitalized patients: presentation, causative pathogens, and outcome. Bangladesh Med Res Counc Bull. 2012;38(3):98-103. doi: 10.3329/bmrcb.v38i3.14336.